nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.549	1	CpDpCtD
Entacapone—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.199	1	CbGbCtD
Entacapone—UGT1A9—kidney—type 2 diabetes mellitus	0.000474	0.165	CbGeAlD
Entacapone—COMT—islet of Langerhans—type 2 diabetes mellitus	0.000367	0.128	CbGeAlD
Entacapone—UGT1A9—liver—type 2 diabetes mellitus	0.0003	0.104	CbGeAlD
Entacapone—COMT—nephron tubule—type 2 diabetes mellitus	0.000296	0.103	CbGeAlD
Entacapone—COMT—cardiovascular system—type 2 diabetes mellitus	0.000266	0.0924	CbGeAlD
Entacapone—COMT—kidney—type 2 diabetes mellitus	0.00026	0.0905	CbGeAlD
Entacapone—COMT—pancreas—type 2 diabetes mellitus	0.000258	0.0899	CbGeAlD
Entacapone—COMT—cortex of kidney—type 2 diabetes mellitus	0.000253	0.0881	CbGeAlD
Entacapone—COMT—adipose tissue—type 2 diabetes mellitus	0.000234	0.0815	CbGeAlD
Entacapone—COMT—liver—type 2 diabetes mellitus	0.000164	0.0572	CbGeAlD
Entacapone—UGT1A9—Biological oxidations—MTR—type 2 diabetes mellitus	0.000147	0.00235	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000147	0.00234	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000146	0.00232	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000142	0.00227	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000142	0.00227	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1A—type 2 diabetes mellitus	0.000142	0.00226	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.00014	0.00224	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PPARGC1A—type 2 diabetes mellitus	0.000137	0.00219	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—type 2 diabetes mellitus	0.000134	0.00214	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000133	0.00213	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000133	0.00211	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000127	0.00203	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000127	0.00202	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000126	0.00202	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF1—type 2 diabetes mellitus	0.000124	0.00198	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—type 2 diabetes mellitus	0.000122	0.00194	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCR—type 2 diabetes mellitus	0.000121	0.00192	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CD36—type 2 diabetes mellitus	0.000119	0.0019	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000118	0.00188	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	0.000117	0.00186	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—type 2 diabetes mellitus	0.000116	0.00186	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000116	0.00185	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000116	0.00185	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000115	0.00183	CbGpPWpGaD
Entacapone—COMT—Metabolism—BHMT—type 2 diabetes mellitus	0.000113	0.00181	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000113	0.00181	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000112	0.00178	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000111	0.00176	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PPARA—type 2 diabetes mellitus	0.00011	0.00176	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000109	0.00174	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GNB3—type 2 diabetes mellitus	0.000109	0.00174	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000109	0.00174	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—type 2 diabetes mellitus	0.000108	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—AGT—type 2 diabetes mellitus	0.000107	0.00171	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—type 2 diabetes mellitus	0.000105	0.00167	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	0.000104	0.00166	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—APOA1—type 2 diabetes mellitus	0.000104	0.00165	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000102	0.00163	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	0.000102	0.00163	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000102	0.00162	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—type 2 diabetes mellitus	0.000101	0.00162	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGDS—type 2 diabetes mellitus	9.92e-05	0.00158	CbGpPWpGaD
Entacapone—COMT—Metabolism—AANAT—type 2 diabetes mellitus	9.92e-05	0.00158	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	9.83e-05	0.00157	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—AGER—type 2 diabetes mellitus	9.8e-05	0.00156	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	9.74e-05	0.00155	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ADCY5—type 2 diabetes mellitus	9.71e-05	0.00155	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	9.58e-05	0.00153	CbGpPWpGaD
Entacapone—COMT—Metabolism—CDO1—type 2 diabetes mellitus	9.4e-05	0.0015	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPD2—type 2 diabetes mellitus	9.4e-05	0.0015	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—type 2 diabetes mellitus	9.26e-05	0.00148	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	9.14e-05	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	9.14e-05	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	9.14e-05	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—type 2 diabetes mellitus	9.13e-05	0.00146	CbGpPWpGaD
Entacapone—COMT—Metabolism—AK1—type 2 diabetes mellitus	8.97e-05	0.00143	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—type 2 diabetes mellitus	8.94e-05	0.00143	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—type 2 diabetes mellitus	8.91e-05	0.00142	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	8.79e-05	0.0014	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CALM1—type 2 diabetes mellitus	8.34e-05	0.00133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	8.29e-05	0.00132	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC5A4—type 2 diabetes mellitus	8.28e-05	0.00132	CbGpPWpGaD
Entacapone—COMT—Metabolism—MAT1A—type 2 diabetes mellitus	8.28e-05	0.00132	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	8.15e-05	0.0013	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—type 2 diabetes mellitus	8.01e-05	0.00128	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.99e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—ND1—type 2 diabetes mellitus	7.99e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—ENPP1—type 2 diabetes mellitus	7.99e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—G6PC—type 2 diabetes mellitus	7.99e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—HBA2—type 2 diabetes mellitus	7.99e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Neuronal System—PRKCB—type 2 diabetes mellitus	7.84e-05	0.00125	CbGpPWpGaD
Entacapone—COMT—Metabolism—GCGR—type 2 diabetes mellitus	7.74e-05	0.00123	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—type 2 diabetes mellitus	7.45e-05	0.00119	CbGpPWpGaD
Entacapone—COMT—Metabolism—OXCT1—type 2 diabetes mellitus	7.31e-05	0.00117	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYTB—type 2 diabetes mellitus	7.31e-05	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—type 2 diabetes mellitus	7.22e-05	0.00115	CbGpPWpGaD
Entacapone—COMT—Metabolism—SRD5A1—type 2 diabetes mellitus	7.12e-05	0.00114	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—type 2 diabetes mellitus	6.99e-05	0.00111	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	6.93e-05	0.00111	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	6.93e-05	0.00111	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BHMT—type 2 diabetes mellitus	6.8e-05	0.00108	CbGpPWpGaD
Entacapone—COMT—Metabolism—STAR—type 2 diabetes mellitus	6.8e-05	0.00108	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD17B3—type 2 diabetes mellitus	6.8e-05	0.00108	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACACA—type 2 diabetes mellitus	6.8e-05	0.00108	CbGpPWpGaD
Entacapone—COMT—Metabolism—CBS—type 2 diabetes mellitus	6.52e-05	0.00104	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCC8—type 2 diabetes mellitus	6.52e-05	0.00104	CbGpPWpGaD
Entacapone—Angioedema—Losartan—type 2 diabetes mellitus	6.33e-05	0.000341	CcSEcCtD
Entacapone—Insomnia—Valsartan—type 2 diabetes mellitus	6.32e-05	0.00034	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.3e-05	0.000339	CcSEcCtD
Entacapone—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000338	CcSEcCtD
Entacapone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.27e-05	0.000338	CcSEcCtD
Entacapone—COMT—Metabolism—COX2—type 2 diabetes mellitus	6.27e-05	0.001	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC5A2—type 2 diabetes mellitus	6.27e-05	0.001	CbGpPWpGaD
Entacapone—Myalgia—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000337	CcSEcCtD
Entacapone—Chest pain—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000337	CcSEcCtD
Entacapone—Shock—Metformin—type 2 diabetes mellitus	6.27e-05	0.000337	CcSEcCtD
Entacapone—Insomnia—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000336	CcSEcCtD
Entacapone—Malaise—Losartan—type 2 diabetes mellitus	6.25e-05	0.000336	CcSEcCtD
Entacapone—Anxiety—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000336	CcSEcCtD
Entacapone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.25e-05	0.000336	CcSEcCtD
Entacapone—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.25e-05	0.000336	CcSEcCtD
Entacapone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.24e-05	0.000336	CcSEcCtD
Entacapone—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000336	CcSEcCtD
Entacapone—Vertigo—Losartan—type 2 diabetes mellitus	6.23e-05	0.000335	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000335	CcSEcCtD
Entacapone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.22e-05	0.000335	CcSEcCtD
Entacapone—Somnolence—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000335	CcSEcCtD
Entacapone—Syncope—Losartan—type 2 diabetes mellitus	6.21e-05	0.000335	CcSEcCtD
Entacapone—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000334	CcSEcCtD
Entacapone—Leukopenia—Losartan—type 2 diabetes mellitus	6.2e-05	0.000334	CcSEcCtD
Entacapone—Discomfort—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000333	CcSEcCtD
Entacapone—Skin disorder—Metformin—type 2 diabetes mellitus	6.19e-05	0.000333	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA6—type 2 diabetes mellitus	6.16e-05	0.000983	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—type 2 diabetes mellitus	6.16e-05	0.000982	CbGpPWpGaD
Entacapone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.16e-05	0.000331	CcSEcCtD
Entacapone—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.16e-05	0.000331	CcSEcCtD
Entacapone—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.13e-05	0.00033	CcSEcCtD
Entacapone—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.00033	CcSEcCtD
Entacapone—Palpitations—Losartan—type 2 diabetes mellitus	6.12e-05	0.00033	CcSEcCtD
Entacapone—Nausea—Glimepiride—type 2 diabetes mellitus	6.11e-05	0.000329	CcSEcCtD
Entacapone—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.09e-05	0.000328	CcSEcCtD
Entacapone—Nausea—Sitagliptin—type 2 diabetes mellitus	6.09e-05	0.000328	CcSEcCtD
Entacapone—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.08e-05	0.000327	CcSEcCtD
Entacapone—Asthenia—Glyburide—type 2 diabetes mellitus	6.08e-05	0.000327	CcSEcCtD
Entacapone—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000327	CcSEcCtD
Entacapone—Anorexia—Metformin—type 2 diabetes mellitus	6.07e-05	0.000327	CcSEcCtD
Entacapone—COMT—Metabolism—UCP2—type 2 diabetes mellitus	6.06e-05	0.000966	CbGpPWpGaD
Entacapone—COMT—Metabolism—UCP3—type 2 diabetes mellitus	6.06e-05	0.000966	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD11B1—type 2 diabetes mellitus	6.06e-05	0.000966	CbGpPWpGaD
Entacapone—Cough—Losartan—type 2 diabetes mellitus	6.05e-05	0.000325	CcSEcCtD
Entacapone—Urticaria—Gliclazide—type 2 diabetes mellitus	6.05e-05	0.000325	CcSEcCtD
Entacapone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000325	CcSEcCtD
Entacapone—Alopecia—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000325	CcSEcCtD
Entacapone—Fatigue—Valsartan—type 2 diabetes mellitus	6.03e-05	0.000325	CcSEcCtD
Entacapone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.02e-05	0.000324	CcSEcCtD
Entacapone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.02e-05	0.000324	CcSEcCtD
Entacapone—Oedema—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000323	CcSEcCtD
Entacapone—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000323	CcSEcCtD
Entacapone—Pruritus—Glyburide—type 2 diabetes mellitus	6e-05	0.000323	CcSEcCtD
Entacapone—Mental disorder—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000322	CcSEcCtD
Entacapone—Constipation—Valsartan—type 2 diabetes mellitus	5.98e-05	0.000322	CcSEcCtD
Entacapone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.97e-05	0.000321	CcSEcCtD
Entacapone—Fatigue—Orlistat—type 2 diabetes mellitus	5.96e-05	0.000321	CcSEcCtD
Entacapone—Hypotension—Metformin—type 2 diabetes mellitus	5.95e-05	0.00032	CcSEcCtD
Entacapone—Malnutrition—Ramipril—type 2 diabetes mellitus	5.94e-05	0.00032	CcSEcCtD
Entacapone—UGT1A9—Metabolism—AANAT—type 2 diabetes mellitus	5.94e-05	0.000947	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGDS—type 2 diabetes mellitus	5.94e-05	0.000947	CbGpPWpGaD
Entacapone—Shock—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000318	CcSEcCtD
Entacapone—Pain—Orlistat—type 2 diabetes mellitus	5.91e-05	0.000318	CcSEcCtD
Entacapone—Myalgia—Losartan—type 2 diabetes mellitus	5.9e-05	0.000318	CcSEcCtD
Entacapone—Chest pain—Losartan—type 2 diabetes mellitus	5.9e-05	0.000318	CcSEcCtD
Entacapone—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.9e-05	0.000317	CcSEcCtD
Entacapone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.89e-05	0.000317	CcSEcCtD
Entacapone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000317	CcSEcCtD
Entacapone—Anxiety—Losartan—type 2 diabetes mellitus	5.88e-05	0.000316	CcSEcCtD
Entacapone—Rash—Bromocriptine—type 2 diabetes mellitus	5.85e-05	0.000315	CcSEcCtD
Entacapone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.84e-05	0.000314	CcSEcCtD
Entacapone—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000314	CcSEcCtD
Entacapone—Tension—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000314	CcSEcCtD
Entacapone—Discomfort—Losartan—type 2 diabetes mellitus	5.83e-05	0.000314	CcSEcCtD
Entacapone—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000313	CcSEcCtD
Entacapone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000313	CcSEcCtD
Entacapone—Headache—Bromocriptine—type 2 diabetes mellitus	5.81e-05	0.000313	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.8e-05	0.000312	CcSEcCtD
Entacapone—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.8e-05	0.000312	CcSEcCtD
Entacapone—Nervousness—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000311	CcSEcCtD
Entacapone—Dry mouth—Losartan—type 2 diabetes mellitus	5.77e-05	0.000311	CcSEcCtD
Entacapone—Anorexia—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000308	CcSEcCtD
Entacapone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.72e-05	0.000308	CcSEcCtD
Entacapone—Paraesthesia—Metformin—type 2 diabetes mellitus	5.72e-05	0.000308	CcSEcCtD
Entacapone—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000307	CcSEcCtD
Entacapone—Confusional state—Losartan—type 2 diabetes mellitus	5.7e-05	0.000307	CcSEcCtD
Entacapone—COMT—Metabolism—PCK1—type 2 diabetes mellitus	5.7e-05	0.000908	CbGpPWpGaD
Entacapone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.69e-05	0.000306	CcSEcCtD
Entacapone—Dyspnoea—Metformin—type 2 diabetes mellitus	5.68e-05	0.000306	CcSEcCtD
Entacapone—Somnolence—Metformin—type 2 diabetes mellitus	5.66e-05	0.000305	CcSEcCtD
Entacapone—Oedema—Losartan—type 2 diabetes mellitus	5.66e-05	0.000304	CcSEcCtD
Entacapone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.65e-05	0.000304	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	5.65e-05	0.000901	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPD2—type 2 diabetes mellitus	5.63e-05	0.000898	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CDO1—type 2 diabetes mellitus	5.63e-05	0.000898	CbGpPWpGaD
Entacapone—Hypotension—Irbesartan—type 2 diabetes mellitus	5.62e-05	0.000302	CcSEcCtD
Entacapone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000302	CcSEcCtD
Entacapone—Dyspepsia—Metformin—type 2 diabetes mellitus	5.61e-05	0.000302	CcSEcCtD
Entacapone—Tremor—Ramipril—type 2 diabetes mellitus	5.57e-05	0.0003	CcSEcCtD
Entacapone—Shock—Losartan—type 2 diabetes mellitus	5.56e-05	0.0003	CcSEcCtD
Entacapone—Urticaria—Valsartan—type 2 diabetes mellitus	5.56e-05	0.000299	CcSEcCtD
Entacapone—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.55e-05	0.000299	CcSEcCtD
Entacapone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.54e-05	0.000298	CcSEcCtD
Entacapone—Decreased appetite—Metformin—type 2 diabetes mellitus	5.54e-05	0.000298	CcSEcCtD
Entacapone—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.53e-05	0.000298	CcSEcCtD
Entacapone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000297	CcSEcCtD
Entacapone—Nausea—Bromocriptine—type 2 diabetes mellitus	5.51e-05	0.000296	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	5.5e-05	0.000878	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.5e-05	0.000296	CcSEcCtD
Entacapone—Fatigue—Metformin—type 2 diabetes mellitus	5.49e-05	0.000296	CcSEcCtD
Entacapone—Urticaria—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000295	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.000295	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	5.47e-05	0.000872	CbGpPWpGaD
Entacapone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.47e-05	0.000294	CcSEcCtD
Entacapone—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.46e-05	0.000294	CcSEcCtD
Entacapone—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.46e-05	0.000294	CcSEcCtD
Entacapone—Asthenia—Gliclazide—type 2 diabetes mellitus	5.46e-05	0.000294	CcSEcCtD
Entacapone—Agitation—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000294	CcSEcCtD
Entacapone—Constipation—Metformin—type 2 diabetes mellitus	5.45e-05	0.000293	CcSEcCtD
Entacapone—Angioedema—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000292	CcSEcCtD
Entacapone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.00029	CcSEcCtD
Entacapone—Anorexia—Losartan—type 2 diabetes mellitus	5.39e-05	0.00029	CcSEcCtD
Entacapone—Vomiting—Glyburide—type 2 diabetes mellitus	5.39e-05	0.00029	CcSEcCtD
Entacapone—Pruritus—Gliclazide—type 2 diabetes mellitus	5.38e-05	0.00029	CcSEcCtD
Entacapone—UGT1A9—Metabolism—AK1—type 2 diabetes mellitus	5.37e-05	0.000857	CbGpPWpGaD
Entacapone—Malaise—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000288	CcSEcCtD
Entacapone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000288	CcSEcCtD
Entacapone—Rash—Glyburide—type 2 diabetes mellitus	5.34e-05	0.000288	CcSEcCtD
Entacapone—Somnolence—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000288	CcSEcCtD
Entacapone—Dermatitis—Glyburide—type 2 diabetes mellitus	5.34e-05	0.000287	CcSEcCtD
Entacapone—Vertigo—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000287	CcSEcCtD
Entacapone—COMT—Metabolism—HK1—type 2 diabetes mellitus	5.33e-05	0.000851	CbGpPWpGaD
Entacapone—Syncope—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000287	CcSEcCtD
Entacapone—Leukopenia—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000286	CcSEcCtD
Entacapone—Headache—Glyburide—type 2 diabetes mellitus	5.31e-05	0.000286	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	5.31e-05	0.000847	CbGpPWpGaD
Entacapone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000285	CcSEcCtD
Entacapone—Hypotension—Losartan—type 2 diabetes mellitus	5.28e-05	0.000284	CcSEcCtD
Entacapone—Palpitations—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000283	CcSEcCtD
Entacapone—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.25e-05	0.000282	CcSEcCtD
Entacapone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.22e-05	0.000281	CcSEcCtD
Entacapone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000281	CcSEcCtD
Entacapone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.21e-05	0.00028	CcSEcCtD
Entacapone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.21e-05	0.00028	CcSEcCtD
Entacapone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000279	CcSEcCtD
Entacapone—Cough—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000279	CcSEcCtD
Entacapone—Fatigue—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000279	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.15e-05	0.000277	CcSEcCtD
Entacapone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000277	CcSEcCtD
Entacapone—COMT—Metabolism—GCKR—type 2 diabetes mellitus	5.15e-05	0.000821	CbGpPWpGaD
Entacapone—COMT—Metabolism—LPA—type 2 diabetes mellitus	5.15e-05	0.000821	CbGpPWpGaD
Entacapone—COMT—Metabolism—KCNJ11—type 2 diabetes mellitus	5.15e-05	0.000821	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD3B2—type 2 diabetes mellitus	5.15e-05	0.000821	CbGpPWpGaD
Entacapone—Convulsion—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000277	CcSEcCtD
Entacapone—Pain—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000277	CcSEcCtD
Entacapone—Constipation—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000277	CcSEcCtD
Entacapone—Insomnia—Losartan—type 2 diabetes mellitus	5.12e-05	0.000275	CcSEcCtD
Entacapone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000274	CcSEcCtD
Entacapone—Paraesthesia—Losartan—type 2 diabetes mellitus	5.08e-05	0.000273	CcSEcCtD
Entacapone—Urticaria—Metformin—type 2 diabetes mellitus	5.06e-05	0.000272	CcSEcCtD
Entacapone—Myalgia—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000272	CcSEcCtD
Entacapone—Chest pain—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000272	CcSEcCtD
Entacapone—Dyspnoea—Losartan—type 2 diabetes mellitus	5.04e-05	0.000271	CcSEcCtD
Entacapone—Anxiety—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000271	CcSEcCtD
Entacapone—Nausea—Glyburide—type 2 diabetes mellitus	5.03e-05	0.000271	CcSEcCtD
Entacapone—Abdominal pain—Metformin—type 2 diabetes mellitus	5.03e-05	0.000271	CcSEcCtD
Entacapone—Dizziness—Gliclazide—type 2 diabetes mellitus	5.03e-05	0.000271	CcSEcCtD
Entacapone—Somnolence—Losartan—type 2 diabetes mellitus	5.03e-05	0.000271	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.02e-05	0.00027	CcSEcCtD
Entacapone—Asthenia—Valsartan—type 2 diabetes mellitus	5.02e-05	0.00027	CcSEcCtD
Entacapone—Discomfort—Ramipril—type 2 diabetes mellitus	5e-05	0.000269	CcSEcCtD
Entacapone—Dyspepsia—Losartan—type 2 diabetes mellitus	4.98e-05	0.000268	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC5A4—type 2 diabetes mellitus	4.96e-05	0.000791	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MAT1A—type 2 diabetes mellitus	4.96e-05	0.000791	CbGpPWpGaD
Entacapone—Asthenia—Orlistat—type 2 diabetes mellitus	4.96e-05	0.000267	CcSEcCtD
Entacapone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000267	CcSEcCtD
Entacapone—Pruritus—Valsartan—type 2 diabetes mellitus	4.95e-05	0.000266	CcSEcCtD
Entacapone—Dry mouth—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000266	CcSEcCtD
Entacapone—COMT—Metabolism—ALDOB—type 2 diabetes mellitus	4.94e-05	0.000788	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.94e-05	0.000787	CbGpPWpGaD
Entacapone—Decreased appetite—Losartan—type 2 diabetes mellitus	4.92e-05	0.000265	CcSEcCtD
Entacapone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000265	CcSEcCtD
Entacapone—Confusional state—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000263	CcSEcCtD
Entacapone—Pruritus—Orlistat—type 2 diabetes mellitus	4.89e-05	0.000263	CcSEcCtD
Entacapone—Fatigue—Losartan—type 2 diabetes mellitus	4.88e-05	0.000262	CcSEcCtD
Entacapone—Oedema—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000261	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4.85e-05	0.000773	CbGpPWpGaD
Entacapone—Vomiting—Gliclazide—type 2 diabetes mellitus	4.84e-05	0.00026	CcSEcCtD
Entacapone—Constipation—Losartan—type 2 diabetes mellitus	4.84e-05	0.00026	CcSEcCtD
Entacapone—Pain—Losartan—type 2 diabetes mellitus	4.84e-05	0.00026	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	4.8e-05	0.000766	CbGpPWpGaD
Entacapone—Rash—Gliclazide—type 2 diabetes mellitus	4.8e-05	0.000258	CcSEcCtD
Entacapone—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000258	CcSEcCtD
Entacapone—UGT1A9—Metabolism—G6PC—type 2 diabetes mellitus	4.79e-05	0.000764	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.79e-05	0.000764	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HBA2—type 2 diabetes mellitus	4.79e-05	0.000764	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ND1—type 2 diabetes mellitus	4.79e-05	0.000764	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENPP1—type 2 diabetes mellitus	4.79e-05	0.000764	CbGpPWpGaD
Entacapone—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.78e-05	0.000258	CcSEcCtD
Entacapone—Urticaria—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000257	CcSEcCtD
Entacapone—Shock—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000257	CcSEcCtD
Entacapone—Headache—Gliclazide—type 2 diabetes mellitus	4.77e-05	0.000257	CcSEcCtD
Entacapone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000256	CcSEcCtD
Entacapone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000256	CcSEcCtD
Entacapone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000256	CcSEcCtD
Entacapone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000256	CcSEcCtD
Entacapone—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.73e-05	0.000254	CcSEcCtD
Entacapone—Skin disorder—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000254	CcSEcCtD
Entacapone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000252	CcSEcCtD
Entacapone—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.66e-05	0.000251	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GCGR—type 2 diabetes mellitus	4.64e-05	0.00074	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.62e-05	0.000249	CcSEcCtD
Entacapone—Dizziness—Valsartan—type 2 diabetes mellitus	4.62e-05	0.000249	CcSEcCtD
Entacapone—Anorexia—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000249	CcSEcCtD
Entacapone—COMT—Metabolism—GLP1R—type 2 diabetes mellitus	4.59e-05	0.000732	CbGpPWpGaD
Entacapone—Dizziness—Orlistat—type 2 diabetes mellitus	4.57e-05	0.000246	CcSEcCtD
Entacapone—Asthenia—Metformin—type 2 diabetes mellitus	4.57e-05	0.000246	CcSEcCtD
Entacapone—Hypotension—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000244	CcSEcCtD
Entacapone—Nausea—Gliclazide—type 2 diabetes mellitus	4.52e-05	0.000243	CcSEcCtD
Entacapone—Pruritus—Metformin—type 2 diabetes mellitus	4.51e-05	0.000243	CcSEcCtD
Entacapone—Urticaria—Losartan—type 2 diabetes mellitus	4.49e-05	0.000242	CcSEcCtD
Entacapone—Body temperature increased—Losartan—type 2 diabetes mellitus	4.47e-05	0.000241	CcSEcCtD
Entacapone—Abdominal pain—Losartan—type 2 diabetes mellitus	4.47e-05	0.000241	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	4.46e-05	0.000712	CbGpPWpGaD
Entacapone—Vomiting—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000239	CcSEcCtD
Entacapone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000238	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000238	CcSEcCtD
Entacapone—Rash—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000237	CcSEcCtD
Entacapone—Dermatitis—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000237	CcSEcCtD
Entacapone—Vomiting—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000236	CcSEcCtD
Entacapone—Insomnia—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000236	CcSEcCtD
Entacapone—Headache—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000236	CcSEcCtD
Entacapone—UGT1A9—Metabolism—OXCT1—type 2 diabetes mellitus	4.38e-05	0.000699	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYTB—type 2 diabetes mellitus	4.38e-05	0.000699	CbGpPWpGaD
Entacapone—Diarrhoea—Metformin—type 2 diabetes mellitus	4.36e-05	0.000235	CcSEcCtD
Entacapone—Rash—Orlistat—type 2 diabetes mellitus	4.36e-05	0.000235	CcSEcCtD
Entacapone—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000234	CcSEcCtD
Entacapone—Dermatitis—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000234	CcSEcCtD
Entacapone—Headache—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000233	CcSEcCtD
Entacapone—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000233	CcSEcCtD
Entacapone—Asthenia—Irbesartan—type 2 diabetes mellitus	4.31e-05	0.000232	CcSEcCtD
Entacapone—Somnolence—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000232	CcSEcCtD
Entacapone—COMT—Metabolism—SLC2A2—type 2 diabetes mellitus	4.29e-05	0.000684	CbGpPWpGaD
Entacapone—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.27e-05	0.00023	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SRD5A1—type 2 diabetes mellitus	4.27e-05	0.000681	CbGpPWpGaD
Entacapone—Pruritus—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000229	CcSEcCtD
Entacapone—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000227	CcSEcCtD
Entacapone—Dizziness—Metformin—type 2 diabetes mellitus	4.21e-05	0.000227	CcSEcCtD
Entacapone—COMT—Metabolism—MTR—type 2 diabetes mellitus	4.2e-05	0.00067	CbGpPWpGaD
Entacapone—COMT—Metabolism—CPT1A—type 2 diabetes mellitus	4.2e-05	0.00067	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000225	CcSEcCtD
Entacapone—Fatigue—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000225	CcSEcCtD
Entacapone—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.17e-05	0.000224	CcSEcCtD
Entacapone—Nausea—Valsartan—type 2 diabetes mellitus	4.15e-05	0.000224	CcSEcCtD
Entacapone—Constipation—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000223	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—type 2 diabetes mellitus	4.14e-05	0.00066	CbGpPWpGaD
Entacapone—COMT—Metabolism—NAMPT—type 2 diabetes mellitus	4.12e-05	0.000657	CbGpPWpGaD
Entacapone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000221	CcSEcCtD
Entacapone—Nausea—Orlistat—type 2 diabetes mellitus	4.1e-05	0.000221	CcSEcCtD
Entacapone—COMT—Metabolism—HBA1—type 2 diabetes mellitus	4.09e-05	0.000653	CbGpPWpGaD
Entacapone—COMT—Metabolism—LIPC—type 2 diabetes mellitus	4.09e-05	0.000653	CbGpPWpGaD
Entacapone—COMT—Metabolism—GCK—type 2 diabetes mellitus	4.09e-05	0.000653	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B3—type 2 diabetes mellitus	4.07e-05	0.000649	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—STAR—type 2 diabetes mellitus	4.07e-05	0.000649	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACACA—type 2 diabetes mellitus	4.07e-05	0.000649	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP11A1—type 2 diabetes mellitus	4.07e-05	0.000649	CbGpPWpGaD
Entacapone—Asthenia—Losartan—type 2 diabetes mellitus	4.06e-05	0.000218	CcSEcCtD
Entacapone—Vomiting—Metformin—type 2 diabetes mellitus	4.05e-05	0.000218	CcSEcCtD
Entacapone—Rash—Metformin—type 2 diabetes mellitus	4.02e-05	0.000216	CcSEcCtD
Entacapone—Dermatitis—Metformin—type 2 diabetes mellitus	4.01e-05	0.000216	CcSEcCtD
Entacapone—Pruritus—Losartan—type 2 diabetes mellitus	4e-05	0.000215	CcSEcCtD
Entacapone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4e-05	0.000215	CcSEcCtD
Entacapone—COMT—Metabolism—SLC9A1—type 2 diabetes mellitus	3.99e-05	0.000637	CbGpPWpGaD
Entacapone—Headache—Metformin—type 2 diabetes mellitus	3.99e-05	0.000215	CcSEcCtD
Entacapone—Dizziness—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000214	CcSEcCtD
Entacapone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000213	CcSEcCtD
Entacapone—COMT—Metabolism—CETP—type 2 diabetes mellitus	3.95e-05	0.00063	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CBS—type 2 diabetes mellitus	3.9e-05	0.000623	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCC8—type 2 diabetes mellitus	3.9e-05	0.000623	CbGpPWpGaD
Entacapone—Diarrhoea—Losartan—type 2 diabetes mellitus	3.87e-05	0.000208	CcSEcCtD
Entacapone—Urticaria—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000207	CcSEcCtD
Entacapone—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000206	CcSEcCtD
Entacapone—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000206	CcSEcCtD
Entacapone—Vomiting—Irbesartan—type 2 diabetes mellitus	3.82e-05	0.000206	CcSEcCtD
Entacapone—Rash—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000204	CcSEcCtD
Entacapone—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000204	CcSEcCtD
Entacapone—Nausea—Metformin—type 2 diabetes mellitus	3.78e-05	0.000204	CcSEcCtD
Entacapone—Headache—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000203	CcSEcCtD
Entacapone—UGT1A9—Metabolism—COX2—type 2 diabetes mellitus	3.76e-05	0.000599	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A2—type 2 diabetes mellitus	3.76e-05	0.000599	CbGpPWpGaD
Entacapone—Dizziness—Losartan—type 2 diabetes mellitus	3.74e-05	0.000201	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA6—type 2 diabetes mellitus	3.69e-05	0.000589	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.69e-05	0.000588	CbGpPWpGaD
Entacapone—COMT—Metabolism—PSMD6—type 2 diabetes mellitus	3.67e-05	0.000585	CbGpPWpGaD
Entacapone—COMT—Metabolism—SREBF1—type 2 diabetes mellitus	3.67e-05	0.000585	CbGpPWpGaD
Entacapone—COMT—Metabolism—SNAP25—type 2 diabetes mellitus	3.67e-05	0.000585	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UCP3—type 2 diabetes mellitus	3.63e-05	0.000579	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UCP2—type 2 diabetes mellitus	3.63e-05	0.000579	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD11B1—type 2 diabetes mellitus	3.63e-05	0.000579	CbGpPWpGaD
Entacapone—COMT—Metabolism—CTGF—type 2 diabetes mellitus	3.6e-05	0.000575	CbGpPWpGaD
Entacapone—Vomiting—Losartan—type 2 diabetes mellitus	3.6e-05	0.000194	CcSEcCtD
Entacapone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000192	CcSEcCtD
Entacapone—COMT—Metabolism—HMGCR—type 2 diabetes mellitus	3.57e-05	0.000569	CbGpPWpGaD
Entacapone—Nausea—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000192	CcSEcCtD
Entacapone—Rash—Losartan—type 2 diabetes mellitus	3.57e-05	0.000192	CcSEcCtD
Entacapone—Dermatitis—Losartan—type 2 diabetes mellitus	3.56e-05	0.000192	CcSEcCtD
Entacapone—Headache—Losartan—type 2 diabetes mellitus	3.54e-05	0.000191	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.52e-05	0.000561	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADRA2A—type 2 diabetes mellitus	3.49e-05	0.000557	CbGpPWpGaD
Entacapone—Asthenia—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000187	CcSEcCtD
Entacapone—Pruritus—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000185	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PCK1—type 2 diabetes mellitus	3.41e-05	0.000544	CbGpPWpGaD
Entacapone—Nausea—Losartan—type 2 diabetes mellitus	3.36e-05	0.000181	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.36e-05	0.000536	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2E1—type 2 diabetes mellitus	3.36e-05	0.000535	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC2A1—type 2 diabetes mellitus	3.32e-05	0.000529	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP1A2—type 2 diabetes mellitus	3.32e-05	0.000529	CbGpPWpGaD
Entacapone—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000179	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.28e-05	0.000523	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP3A4—type 2 diabetes mellitus	3.24e-05	0.000516	CbGpPWpGaD
Entacapone—Dizziness—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000173	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HK1—type 2 diabetes mellitus	3.19e-05	0.00051	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.19e-05	0.000509	CbGpPWpGaD
Entacapone—COMT—Metabolism—GCG—type 2 diabetes mellitus	3.18e-05	0.000508	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC2A4—type 2 diabetes mellitus	3.18e-05	0.000508	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD3B2—type 2 diabetes mellitus	3.09e-05	0.000492	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GCKR—type 2 diabetes mellitus	3.09e-05	0.000492	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—KCNJ11—type 2 diabetes mellitus	3.09e-05	0.000492	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPA—type 2 diabetes mellitus	3.09e-05	0.000492	CbGpPWpGaD
Entacapone—Vomiting—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000166	CcSEcCtD
Entacapone—Rash—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000165	CcSEcCtD
Entacapone—Dermatitis—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000164	CcSEcCtD
Entacapone—Headache—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000164	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.97e-05	0.000473	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDOB—type 2 diabetes mellitus	2.96e-05	0.000472	CbGpPWpGaD
Entacapone—Nausea—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000155	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.87e-05	0.000458	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.82e-05	0.000449	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.78e-05	0.000444	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GLP1R—type 2 diabetes mellitus	2.75e-05	0.000439	CbGpPWpGaD
Entacapone—COMT—Metabolism—GNB3—type 2 diabetes mellitus	2.74e-05	0.000437	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.74e-05	0.000437	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMOX1—type 2 diabetes mellitus	2.73e-05	0.000435	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAT—type 2 diabetes mellitus	2.69e-05	0.00043	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOB—type 2 diabetes mellitus	2.61e-05	0.000417	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.57e-05	0.00041	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—type 2 diabetes mellitus	2.54e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CPT1A—type 2 diabetes mellitus	2.52e-05	0.000401	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTR—type 2 diabetes mellitus	2.52e-05	0.000401	CbGpPWpGaD
Entacapone—COMT—Metabolism—LPL—type 2 diabetes mellitus	2.5e-05	0.000398	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NAMPT—type 2 diabetes mellitus	2.47e-05	0.000393	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.45e-05	0.000391	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LIPC—type 2 diabetes mellitus	2.45e-05	0.000391	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HBA1—type 2 diabetes mellitus	2.45e-05	0.000391	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GCK—type 2 diabetes mellitus	2.45e-05	0.000391	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-05	0.00039	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.44e-05	0.000389	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPX1—type 2 diabetes mellitus	2.44e-05	0.000389	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.39e-05	0.000382	CbGpPWpGaD
Entacapone—COMT—Metabolism—CD36—type 2 diabetes mellitus	2.37e-05	0.000378	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CETP—type 2 diabetes mellitus	2.36e-05	0.000377	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-05	0.000374	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTHFR—type 2 diabetes mellitus	2.25e-05	0.000359	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARA—type 2 diabetes mellitus	2.21e-05	0.000352	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.2e-05	0.000352	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SREBF1—type 2 diabetes mellitus	2.2e-05	0.000351	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SNAP25—type 2 diabetes mellitus	2.2e-05	0.000351	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PSMD6—type 2 diabetes mellitus	2.2e-05	0.000351	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CTGF—type 2 diabetes mellitus	2.16e-05	0.000344	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMGCR—type 2 diabetes mellitus	2.14e-05	0.000341	CbGpPWpGaD
Entacapone—COMT—Metabolism—AGT—type 2 diabetes mellitus	2.14e-05	0.000341	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.11e-05	0.000336	CbGpPWpGaD
Entacapone—COMT—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-05	0.000335	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.09e-05	0.000334	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOE—type 2 diabetes mellitus	2.09e-05	0.000334	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA1—type 2 diabetes mellitus	2.07e-05	0.00033	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.01e-05	0.000321	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.94e-05	0.000309	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.93e-05	0.000308	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GCG—type 2 diabetes mellitus	1.91e-05	0.000304	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.91e-05	0.000304	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-05	0.000291	CbGpPWpGaD
Entacapone—COMT—Metabolism—INS—type 2 diabetes mellitus	1.79e-05	0.000285	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GNB3—type 2 diabetes mellitus	1.64e-05	0.000262	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.64e-05	0.000262	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—type 2 diabetes mellitus	1.64e-05	0.000261	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—type 2 diabetes mellitus	1.64e-05	0.000261	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAT—type 2 diabetes mellitus	1.61e-05	0.000257	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-05	0.00025	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-05	0.00025	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOB—type 2 diabetes mellitus	1.57e-05	0.00025	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—type 2 diabetes mellitus	1.52e-05	0.000243	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPL—type 2 diabetes mellitus	1.5e-05	0.000239	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADCY5—type 2 diabetes mellitus	1.46e-05	0.000234	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPX1—type 2 diabetes mellitus	1.46e-05	0.000233	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-05	0.000229	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CD36—type 2 diabetes mellitus	1.42e-05	0.000227	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.4e-05	0.000224	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—type 2 diabetes mellitus	1.35e-05	0.000215	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARA—type 2 diabetes mellitus	1.32e-05	0.000211	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AGT—type 2 diabetes mellitus	1.28e-05	0.000204	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	1.26e-05	0.000201	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	1.25e-05	0.0002	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	1.24e-05	0.000198	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	1.09e-05	0.000174	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	1.07e-05	0.000171	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	9.82e-06	0.000157	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	9.39e-06	0.00015	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	9.39e-06	0.00015	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	8.59e-06	0.000137	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—type 2 diabetes mellitus	7.21e-06	0.000115	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	4.32e-06	6.89e-05	CbGpPWpGaD
